Amgen Inc. Canadian Depositary Receipt (AMGN)
TSX
30.70
+0.66 (+2.20%)
Closed
Oct 9, 2026
Day's Range
30.3630.74
52 wk Range
23.9532.94
Financial Statements - AMGN - Amgen Inc. Canadian Depositary Receipt
Revenue
36.75B▼ 19.6%
Net Income
7.71B▲ 37.9%Net Margin 21.0%
EBITDA
16.89B▼ 7.4%
Free Cash Flow
8.10B▼ 43.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 36.75B | 45.68B |
| Cost of Goods | 12.03B | 17.57B |
| Gross Profit | 24.71B | 28.11B |
 Operating Expense | - | - |
| Operating Income | 9.08B | 9.92B |
| Non-Operating Interest | - | - |
| Other Income Expense | 2.65B | 691.68M |
| Pre Tax Income | 8.97B | 6.30B |
| Income Tax | 1.26B | 709.45M |
| Net Income | 7.71B | 5.59B |
| EPS Basic | 0.788731 | 0.419409 |
| EPS Diluted | 0.783226 | 0.416106 |
| Basic Shares Outstanding | 9.77B | 13.33B |
| Diluted Shares Outstanding | 9.77B | 13.33B |
| Ebit | 11.73B | 10.61B |
| Ebitda | 16.89B | 18.25B |
| Net Income Continuous Operations | 7.71B | 5.59B |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
